Boston Business Journal by Julie M. Donnelly, Reporter
Boston Scientific Corp. (NYSE: BSX) is embroiled in a wide-ranging cavalcade of product liability personal injury cases that plaintiffs’ lawyers say could rival the silicone breast-implant settlements in the 1990s, which cost Dow Corning $3.2 billion.
The Natick medical device firm is one of 33 companies, including Johnson & Johnson (NYSE: JNJ) and C.R. Bard Inc. (NYSE: BCR), that manufacture transvaginal mesh kits for the treatment of two common gynecological conditions — stress urinary incontinence and pelvic organ prolapse. The devices are alleged to have caused more than 1,000 adverse events, including three deaths.